HI
GSK icon

Harbour Investments’s GSK GSK Stock Holding History

Harbour Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$320K Buy
5,791
+3,487
+151% +$189K ﹤0.01% 1274
2025
Q4 		$113K Sell
2,304
-583
-20% -$27.2K ﹤0.01% 1581
2025
Q3 		$125K Buy
2,887
+1,617
+127% +$63.2K ﹤0.01% 1479
2025
Q2 		$48.8K Sell
1,270
-1,320
-51% -$50.4K ﹤0.01% 1846
2025
Q1 		$100K Buy
2,590
+186
+8% +$6.81K ﹤0.01% 1438
2024
Q4 		$81.3K Buy
2,404
+63
+3% +$2.27K ﹤0.01% 1462
2024
Q3 		$95.7K Buy
2,341
+18
+0.8% +$736 ﹤0.01% 1344
2024
Q2 		$89.4K Buy
2,323
+303
+15% +$12.7K ﹤0.01% 1285
2024
Q1 		$86.6K Sell
2,020
-498
-20% -$20.5K ﹤0.01% 1278
2023
Q4 		$93.3K Buy
2,518
+672
+36% +$24.1K ﹤0.01% 1160
2023
Q3 		$66.9K Sell
1,846
-1,665
-47% -$59.1K ﹤0.01% 1217
2023
Q2 		$125K Sell
3,511
-31
-0.9% -$1.11K 0.01% 971
2023
Q1 		$126K Buy
3,542
+125
+4% +$4.37K 0.01% 946
2022
Q4 		$120K Buy
+3,417
New +$114K 0.01% 936
2021
Q4 		$134K Sell
2,425
-6,982
-74% -$363K 0.01% 854
2021
Q3 		$449K Sell
9,407
-2,896
-24% -$145K 0.01% 683
2021
Q2 		$612K Sell
12,303
-395
-3% -$19K 0.02% 599
2021
Q1 		$566K Buy
+12,698
New +$576K 0.02% 566

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Harbour Investments's GSK Position: Q1 2026 in Review

Harbour Investments increased its GSK (GSK) stake by 151% in Q1 2026, buying an estimated $189K and bringing the position to 5,791 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #1274.

Harbour Investments first reported a position in GSK in Q1 2021 and has held it in 18 quarters since. The position peaked at $612K in Q2 2021. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Harbour Investments held 5,791 shares of GSK worth $320K as of Q1 2026.
  • Harbour Investments bought 3,487 GSK shares in Q1 2026, an estimated $189K.
  • GSK made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #1274 holding.
  • Harbour Investments first reported a position in GSK in Q1 2021 and has held it in 18 quarters since.
  • Harbour Investments's GSK position peaked at $612K in Q2 2021.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.